MedBiomarkers Information

MedBiomarkers’ vision is to accelerate the translation of biomarker research via providing data and software solutions and building biomarker related consortia. The company helps diagnostics and drug discovery companies to effectively incorporate biomarker research into their product pipelines as well as tech transfer offices and biomarker discovery organizations to accelerate the licensing of their inventions. We are a global team of consultants consisting of expertize in every stage of the biomarker discovery and validation process which it rapidly mobilizes to meet the needs of biomarker projects and ensure they are successfully designed and executed. The Medbiomarkers team has extensive experience in the design, execution and reporting of pre-clinical and clinical biomarker studies. These capabilities also uniquely include digital marketing and IP development to assist clients in commercial and marketing matters related to biomarker projects. The team has experience designing and building multi-organizational research consortia with notable examples being within Autism, Major Depressive Disorders (MDD), Parkinson's and Malaria for biomarker research &/or predictive model development. Through these consortia building efforts, Medbiomarkers has developed a strong global network of leading research organizations ranging from Harvard Medical School, Indian Institute of Technology (IIT), UTwente, Novartis and Danone. MedBiomarkers is also developing a biomarker data platform to improve the management of data from projects and make better use of this data opening up opportunities which may have traditionally been overlooked from such projects.